Teselagen provides a biotechnology software platform that automates DNA design, assembly, management, and experimental workflows, allowing users to efficiently handle various biological research processes.

Teselagen

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Metric
Company Name	Teselagen	Ginkgo Bioworks Holdings, Inc.
Symbol		DNA
MSH ID	COM:TESELAGEN	COM:GINKGOBIOWORKS
Market	PRIVATE	STOCKS
Sector	Technology	Healthcare
Industry	Biotechnology	Biotechnology
Country	US	US
Stage		Grant
Employee Count		1.22K
Website	teselagen.com	ginkgobioworks.com
LinkedIn		ginkgo-bioworks
Founders

Metric
Market Cap		725.64M
Enterprise Value
Monthly Web Traffic		20.69K
Web Traffic Growth		-0.17
Valuation
Raised Capital

Metric
Revenue		251.46M
Revenue (LTM)
Revenue (NTM)
Gross Profit		142.64M
EBITDA		-600.68M
Operating Income		-672.23M
Net Income		-892.87M
EPS		-0.46
Diluted EPS		-0.46
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.75
Operating Profit Margin		-3.34
EBITDA Margin		-2.39
Net Profit Margin		-3.55
Return on Equity		-0.65
Return on Assets		-0.54
Return on Capital Employed		-0.51

COM:TESELAGEN

Teselagen

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		-2.78
P/B Ratio		1.90
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		93.70
EV Multiple		-1.34

Metric
Days Sales Outstanding		73.17
Days Payables Outstanding		50.57
Days Inventory Outstanding		0.27
Operating Cycle		46.33
Cash Conversion Cycle		-7.39
Asset Turnover		0.15

Metric
Operating Cash Flow		-295.50M
Free Cash Flow		-336.30M
Cash Flow to Debt		-0.63
Operating Cash Flow/Sales		-1.14
Free Cash Flow Yield		-0.16

Metric
Cash & Equivalents		948.86M
Accounts Receivable		50.07M
Inventory		46K
Goodwill		49.24M
Debt to Capitalization		0.35
Debt to Assets		0.20
Current Ratio		6.78
Quick Ratio		5.98

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.94
R&D to Revenue		2.05
SG&A to Revenue		1.32